Evaluation of Xylitol Wipes as an Oral Hygiene Protocol for Haemophilic Children
NCT ID: NCT05899075
Last Updated: 2023-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2021-12-20
2023-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors
NCT06312475
A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt
NCT04106323
Efficacy and Safety Study of XP12B in Women With Menorrhagia
NCT00386308
PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A
NCT02492984
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors
NCT06569108
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group A
xylitol wipes
group A will receive xylitol wipes and group B will receive placebo wipes
group B
placebo wipes
group A will receive xylitol wipes and group B will receive placebo wipes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
xylitol wipes
group A will receive xylitol wipes and group B will receive placebo wipes
placebo wipes
group A will receive xylitol wipes and group B will receive placebo wipes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged (6-12 years).
* Co-operative.
Exclusion Criteria
6 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdelmageed Mohamed Nazmy Bassiouny Mohamed Harras
BDS, Dentist at the Egyptian Ministry of Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hamdy Badreldin
Role: STUDY_DIRECTOR
AlAzhar U
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AlAzhar U
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
687/3906
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.